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A B S T R A C T
Background
Patellofemoral pain syndrome refers to the clinical presentation of knee pain related to changes in the patellofemoral joint. Patellofemoral
pain syndrome usually has a gradual onset of pain with none of the features associated with other knee diseases or trauma. It is often
treated by physiotherapists, who use a variety of techniques including patellar taping. This involves the application of adhesive sports
medical tape applied directly to the skin over the patella on the front of the knee. Patients often report an instantaneous improvement
in pain and function after the tape is applied, but its longer term effects are uncertain.
Objectives
The objective was to assess the effects, primarily on pain and function, of patellar taping for treating patellofemoral pain syndrome in
adults.
Search methods
We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, the Cochrane Central Register of Controlled
Trials, MEDLINE, CINAHL, EMBASE, PEDro, SPORTDiscus, AMED, reference lists of articles, trial registers and conference
proceedings. All were searched to August 2011.
Selection criteria
Randomised controlled trials and quasi-randomised controlled trials testing the effects of patellar taping on clinically relevant outcomes,
pain and function, in adults with patellofemoral pain syndrome. We excluded studies testing only the immediate effects of tape
application.
Data collection and analysis
Both review authors independently performed study selection, data extraction and assessment of risk of bias. Trialists were contacted
for more information. Data were pooled where possible.
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Main results
Five small heterogeneous randomised controlled trials, all at high risk of performance bias and most at risk of at least one other type of
bias, were included. These involved approximately 200 participants with a diagnosis of patellofemoral pain syndrome. All compared
taping versus control (no or placebo taping) and all included one or more co-interventions given to both taping and control group
participants; this was prescribed exercise in four trials. The intensity and length of treatment was very varied: for example, length of
treatment ranged from one week in one trial to three months in another. A meta-analysis of the visual analogue scale (VAS) pain
data (scale 0 to 10: worst pain), measured in different ways, from four trials (data from 161 knees), found no statistically or clinically
significant difference between taping and non taping in pain at the end of the treatment programmes (mean difference (MD) -0.15;
95% confidence interval (CI) -1.15 to 0.85; random-effects model used given the significant heterogeneity (P < 0.0001)). Data for
other outcomes measuring function and activities of daily living were from single trials only and gave contradictory results.
Authors’ conclusions
The currently available evidence from trials reporting clinically relevant outcomes is low quality and insufficient to draw conclusions
on the effects of taping, whether used on its own or as part of a treatment programme. Further research involving large, preferably
multi-centre, good quality and well reported randomised controlled trials that measure clinically important outcomes and long-term
results is warranted. Before this, consensus is required on the diagnosis of patellofemoral pain syndrome, the standardisation of outcome
measurement and an acceptable approach for patellar taping.
P L A I N L A N G U A G E S U M M A R Y
Taping across the knee cap for adults with persistent pain at the front of the knee (patellofemoral pain)
Pain at the front of the knee (also known as anterior knee pain or patellofemoral pain) is a common problem which particularly affects
those who do some form of sport or exercise. Typically, it gets worse when going up and down stairs, squatting, kneeling and sitting
with the knee bent. It is a distinct and separate condition from knee arthritis.
Such anterior knee pain is often treated by physiotherapists, who use a variety of techniques. One such technique is the use of a simple
piece of adhesive tape across the knee cap to control the positioning of the knee-cap (patella) and potentially reduce the pain during
movement.
The review found five trials, involving around 200 participants with this condition, which compared the clinical use of taping with
no taping. All five studies differed from each other in terms of the type of participants (one trial involved army recruits), length and
schedule of the treatment programme and assessment of outcome. In four trials, participants of both taping and no or placebo taping
groups were prescribed exercises. In part because both the therapist and the patient knew whether they were getting taping, some
caution was necessary in interpreting the study results. Pooled results from four trials (161 knees) for the level of pain at the end of the
treatment programme (ranging for one week to three months) showed no difference between those given taping and those not. Data
for other outcomes measuring function and activities of daily living were from single trials only and gave different results.
The review concluded that the currently available evidence from trials reporting clinically relevant outcomes is and low quality and
insufficient to draw conclusions on the effects of taping. However, before further trials are conducted, some consensus is required to
establish the typical patients, taping technique and the best way of measuring outcome.
B A C K G R O U N D
Description of the condition
Patellofemoral pain syndrome refers to the clinical presenta-
tion of knee pain related to changes in the patellofemoral joint.
Patellofemoral pain syndrome usually has a gradual onset of pain
with none of the features associated with other knee injuries or
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diseases. Authors in the United Kingdom (Anderson 2003), main-
land Europe (Witvrouw 2003), Australia (McConnell 1996) and
the USA (Brechter 2002) have stated that 25% of the adult pop-
ulation present with patellofemoral pain at some point, but have
cited data from studies involving sporting or military cohorts. As a
recent population estimate for adults aged between 19 to 50 years
is just over 25 million in England alone (ONS 2007), these esti-
mates may indicate that patellofemoral pain syndrome is a consid-
erable health burden. However, the true prevalence and incidence
of patellofemoral pain syndrome in the population as a whole re-
mains unknown (Callaghan 2007).
Patellofemoral pain syndrome can cause functional limitations
(Callaghan 1996; Callaghan 2004). The best way to manage the
condition remains controversial and treatment failure rates are re-
ported to be high (Brown 2000). Researchers have shown that
patients may have higher than expected levels of disability (Clark
2000b) and psychological morbidity (Jensen 2005). A significant
number may still experience symptoms many years after diagnosis
(Nimon 1998) and there are concerns that the syndrome may pre-
dispose to osteoarthritis (Utting 2005). However, the possibility
that anterior knee pain is a risk factor for incident patellofemoral
osteoarthritis warrants further attention (Thomas 2010). The ae-
tiology of patellofemoral pain syndrome is also unclear, with
some studies suggesting that biomechanical abnormalities may be
precipitated by occupation, sports or footwear (Cheung 2006).
Higher body mass indices have been observed in patients with
patellofemoral pain syndrome (Clark 2000b) and this apparent
association cannot be ignored given the increasing prevalence of
obesity in society.
Anatomical considerations for this condition
The patellofemoral joint is a complex joint arrangement between
the back of the patella (knee-cap) and the reciprocally shaped distal
end of the femur (thigh bone). The patella is a rounded bone
embedded in the quadriceps tendon and is the largest of its kind
(a sesamoid bone) in the body. Its joint surface has a large flat area
on the outside, a smaller convex area on the inside, which in turn
has a smaller area at its extreme, usually described as the ’odd facet’
(Goodfellow 1976). The patellofemoral joint is a synovial joint
and is the least stable joint in the lower limb; it has six degrees of
freedomofmotion and very large forces ofmultiple times the body
weight are applied rapidly through a wide range of motion during
everyday functional activities (Selfe 2010b). The primary role of
the patella is to increase the efficiency and mechanical advantage
of the large quadriceps muscles on the front of the thigh (Malek
1981). It also has a role in distributing the compressive forces at
the joint by increasing the contact area between patella and thigh
bone. The patella provides a fulcrum for the static and dynamic
stabilisation supports (Malek 1981). The static stabilisers of the
patella are a variety of ligaments, bursae (fluid sacs) and fascial
tissue that keep the patella in its position in the centre of the
knee. The dynamic stabilisers are muscle and tendons, the most
important of which are the quadriceps muscles and, to a lesser
extent, the hamstrings at the back of the thigh.
Description of the intervention
Patellar taping is an inexpensive technique readily and often used
in the treatment of patients with patellofemoral pain syndrome.
The technique involves the application of adhesive sports medical
tape directly to the skin over the patella on the front of the knee.
Usually, this tape is applied by physiotherapists during a treatment
session but it can also be applied by patients at home and left on
during waking hours. A variety of taping methods and techniques
are in use. These include variations in the type of tape (elastic or
rigid), the direction of pull of the tape (medial, lateral, inferior,
superior, rotational, or no directional pull at all) and the number
of layers of tape applied over the patella.
How the intervention might work
The dominant theory from both orthopaedic and physiotherapy
perspectives is that most patellofemoral pain is the result of some
form of patellar malalignment. But although it is purported to
be present in the majority of patients with gradual, non-arthritic
and non-traumatic patellar pain, the same cannot be said for ado-
lescents who usually have patella problems related to growth and
development (Grelsamer 1998). Physical correction of malalign-
ment is just one of the reasons why patellar taping is thought to
be beneficial for patellofemoral pain syndrome and there is an im-
plication that the correction of static stability may restore normal
patellar tracking by also improving dynamic stability. McConnell
1986 originally described patellar taping as part of a treatment pro-
gramme for patellofemoral pain syndrome and theorised that this
technique could alter patellar alignment, enhance contractions of
the vastus medialis oblique (VMO) muscle, and hence decrease
pain. Although these theories how a taping intervention might
work were accepted for many years, subsequent studies have been
contradictory regarding the ability of taping to realign patellar po-
sition (Crossley 2000) and to enhance VMO contractions (Cerny
1995b). Nevertheless, a number of studies have shown that patel-
lar taping does decrease pain in patients with patellofemoral pain
syndrome (for example, Powers 1997b), although the mechanism
for this symptomatic improvement remains unknown (Callaghan
1997; Selfe 2004).
Why it is important to do this review
While the true health burden of patellofemoral pain syndrome
is not known, it is common in young active adults and a source
of long term disability (Clark 2000b; Nimon 1998). The best
way to manage the condition is not known and treatment failures
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are frequent (Brown 2000). Patellar taping is commonly used in
clinical practice for this condition either as a sole technique, or
more commonly in conjunction with an exercise programme. We
set out to systematically review the evidence for patellar taping for
treating patellofemoral pain syndrome.
O B J E C T I V E S
To assess the effects, primarily on pain and function, of patellar
taping for treating patellofemoral pain syndrome in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials and quasi-randomised
controlled trials (amethod of allocating participants to a treatment
that is not strictly random; i.e. by date of birth, hospital record
number, or alternation) evaluating patellar taping for adults with
patellofemoral pain syndrome.
Types of participants
Adults, aged 18 and above, diagnosed with patellofemoral pain
syndrome. Patellofemoral pain syndrome could include other
terms or synonyms associated with the condition (e.g. anterior
knee pain, patella malalignment syndrome, retropatellar pain) as
long as those studies had applied criteria to exclude other causes
of pain not related to the patellofemoral joint. Trials that treated
patients after a patella fracture, patella dislocation or subluxation
or patients with a history of recurrent dislocation and subluxa-
tion were excluded. Also excluded were trials involving patients
with concomitant neurological, rheumatological or cardiovascular
problems.
Types of interventions
We included studies comparing any kind of patellar taping, thus
where patients were randomly allocated to receive any kind of ad-
hesive tape across the patella, versus placebo taping (i.e. tape placed
across the surface of the patella without correction to patella align-
ment) or no taping. Patellar taping could be the only intervention
or appliedwith other interventions, such as home exercises, as long
as the same interventions were provided to the control group as
well.
We excluded studies that compared patellar taping with another
intervention (such as exercises) or that compared composite in-
terventions, that included patellar taping, with no intervention or
different interventions.
Types of outcome measures
We considered the following outcome measures:
1. Pain during activities or at rest
• Patient assessment scales such as (but not exclusively
limited to) the visual analogue scale (VAS) and self-reported
questionnaires subject and sensitive to patellofemoral pain
syndrome such as the Kujala Patellofemoral Pain Score; the
Functional Index Questionnaire; the Modified Functional Index
Questionnaire; and other scoring systems related to the knee
joint or patellofemoral pain syndrome.
2. Function
• Patient functional assessment scales such as (but not
exclusively limited to) the visual analogue scale (VAS) and self-
reported questionnaires subject and sensitive to patellofemoral
pain syndrome such as the Kujala Patellofemoral Pain Score; the
Functional Index Questionnaire; the Modified Functional Index
Questionnaire; and other scoring systems related to the knee
joint or patellofemoral pain syndrome.
3. Activity levels
• Patient activity assessment scales such as (but not
exclusively limited to) the visual analogue scale (VAS) and self-
reported questionnaires subject and sensitive to patellofemoral
pain syndrome such as the Kujala Patellofemoral Pain Score; the
Modified Functional Index Questionnaire (MFIQ); the
Functional Index Questionnaire (FIQ); and other scoring
systems related to the knee joint or patellofemoral pain
syndrome.
4. Quality of life
• Patient quality of life assessment scales such (but not
exclusively limited to) self-reported questionnaires subject and
sensitive to patellofemoral pain syndrome such as the Kujala
Patellofemoral Pain Score; the Functional Index Questionnaire;
the Modified Functional Index Questionnaire, the Western
Ontario and McMaster University Osteoarthritis Index
(WOMAC); and the Medical Outcomes study short form 36
(SF-36).
Timing of outcome assessment
The time points considered are as follows.
1. Immediately after the completion of a treatment programme.
2. Preferably at least six months follow-up when taping is used as
part of a treatment programme.
We did not consider trials where outcome measures such EMG
(electromyogram) data, gait analysis, patellar position or align-
ment were studied without pain evaluation.
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Search methods for identification of studies
Electronic searches
We searched the Cochrane Bone, Joint andMuscle Trauma Group
Specialised Register (August 2011), the Cochrane Central Regis-
ter of Controlled Trials (2011, Issue 5), MEDLINE (1950 to 20
August 2011), EMBASE (1980 to 20 August 2011), CINAHL
(1982 to20August 2011), PEDro - The Physiotherapy Evidence
Database (20 August 2011), SPORTDiscus (1830 to 20 August
2011), AMED (1985 to 20 August 2011). We also searched for
theses via the following databases available through the University
of Manchester and University of Central Lancashire libraries: the
Thesis Canada Protocol; the Australian Digital Thesis Program;
and ProQuest. For conference proceedings we searched the Char-
tered Society of Physiotherapy in-house library catalogue (20 Au-
gust 2011). For ongoing trials we also searched using themetaReg-
ister of Controlled Trials (mRCT) at Current Controlled Trials
(20 August 2011). There were no language restrictions.
In MEDLINE (OVID ONLINE), the search strategy was com-
bined with the first two sections of the optimal MEDLINE
search strategy for randomised controlled trials (Higgins 2005)
(Appendix 1). Search strategies for the Cochrane Central Register
of Controlled Trials, EMBASE, CINAHL, PEDro, SPORTDis-
cus and AMED can also be found in Appendix 1.
Searching other resources
We searched reference lists of articles and contacted experts in the
field in order to identify unpublished trials.
Data collection and analysis
Selection of studies
Both authors (MJC and JS) independently reviewed the title, ab-
stract and descriptors of each paper identified from the results of
the literature searches with the aim of selecting trials for the main
review. We then reviewed the full text of the trials that appeared to
meet the criteria. Consensus was reached between the two authors
without need for third party intervention.
Data extraction and management
Both authors (MJC and JS) independently extracted trial data
using a double extraction process. Details from included studies
were then entered intoRevManbyMJC.Wemade several attempts
to contact trialists for additional information on trial methodology
and missing data.
Assessment of risk of bias in included studies
Both authors (MJC and JS) independently assessed the risk of bias
of included studies using The Cochrane Collaboration’s ’Risk of
bias’ tool (Higgins 2008). We assessed risk of selection bias (based
on an assessment of random sequence generation and allocation
concealment), performance bias (based on assessment of blinding
of participants and therapists administrating the treatment), de-
tection bias (based on assessment of assessor blinding), attrition
bias (based on assessment of completeness of outcome data), and
’other bias’. For ’other bias’, we assessed comparability of the treat-
ment groups at baseline, the inclusion of other care programmes
for the participants, and the monitoring treatment compliance
during the trial. Disagreement was resolved by consensus without
recourse to third party intervention. Neither author was blinded
to the authorship of studies.
Measures of treatment effect
Where available, quantitative data were presented for the out-
comes listed for each trial. Mean differences and 95% confidence
intervals were calculated for continuous data, and risk ratios and
95% confidence intervals were calculated for dichotomous out-
come measures.
Unit of analysis issues
We did not address the potential for unit of analysis issues in our
protocol. However, while the inclusion of bilateral cases in some
trials is a problem, it was irresolvable because of lack of data.
Dealing with missing data
We contacted trial authors for missing data. Where data were
available, we conducted intention-to-treat analyses performed but
otherwise used the data as presented. There were insufficient data
to conduct sensitivity analyses to explore the effects of drop outs
and exclusions.
Assessment of heterogeneity
Heterogeneity between comparable trials was evaluated visually
and its presence tested using the chi-squared test with a P value
of < 0.1 being statistically significant. Consistency between the
studies was also calculated using the I² test and larger values were
considered as an indicator of substantial heterogeneity.
Data synthesis
For each study, the risk ratio (RR) and 95% confidence intervals
(CI) were calculated for dichotomous outcomes and mean dif-
ferences and 95% confidence intervals for continuous outcomes.
While we planned to use the standardised mean difference where
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it was necessary to combine the results from different scales, we
made an exception for pain data that could be converted for pre-
sentation on a 10 cm visual analogue scale. When there was no
heterogeneity, we pooled data using the fixed-effectmodel. If there
was significant heterogeneity, we considered pooling data using
the random-effects model.
Subgroup analysis and investigation of heterogeneity
Subgroup analyses were undertaken within RevMan for trials that
included an exercise co-intervention and those that did not. We
were unable to conduct our two other planned subgroup analyses
to investigate gender (i.e. did females gain more benefit thanmales
from taping?) and the population studied (i.e. trials that focused
on the sporting population, the military population or the general
adult population). We looked at the effect on the pain results from
the exclusion of the only trial testing taping on people with acute
patellofemoral pain.
Sensitivity analysis
There were insufficient data to perform our planned sensitivity
analyses on various aspects of trial methodology such as conceal-
ment of allocation, inclusion and exclusion criteria and account-
ing for missing data. We looked at the effects of analysing the data
with fixed-effect and random-effects models for pain.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
Results of the search
Two hundred and eighty references were retrieved, from which 45
potentially eligible studies were identified. Of these, five studies
were included, 36 were excluded and one study (Miller 2010),
which is only published as a conference abstract, is awaiting as-
sessment. All of the fully reported potentially eligible studies were
published in English language journals except for Nafstad 1996,
which was in Norweigian, andWijnen 1996, which was in Dutch.
Upon translation, both these trials were excluded.
Included studies
Details of all the five individual trials (Clark 2000a; Kowall 1996;
Mason 2011; Tunay 2003; Whittingham 2004) can be found in
the Characteristics of included studies. A summary of these is
presented below.
Design
All five studies were randomised parallel group trials. Three tri-
als (Clark 2000a; Mason 2011; Tunay 2003) had four treatment
groups, but two groups in each of Mason 2011 and Tunay 2003
were excluded because they tested interventions that were out-
side the scope of this review. Kowall 1996 had two groups and
Whittingham 2004 had three groups, of which one was a placebo
control.
Sample sizes
In total, there were approximately 200 participants with a total of
216 knees diagnosed with patellofemoral pain syndrome. All five
trials were small. The sample sizes ranged from 25 participants
in Kowall 1996 to 81 in Clark 2000a. However, the numbers of
participants in individual groups ranged from 10 (Whittingham
2004) to 22 ( Clark 2000a).
Setting
The trials were conducted in one of four countries: Aus-
tralia (Mason 2011), Turkey (Tunay 2003), UK (Clark 2000a;
Whittingham 2004) and USA (Kowall 1996). Two trials were in
the military setting (Tunay 2003; Whittingham 2004).
Participants
All participants had a diagnosis of patellofemoral pain syndrome.
The variety of the criteria used in the trials for this diagnosis is
evident from inspection of the Characteristics of included studies.
Tunay 2003 did not describe the gender mix of their participants,
although the probable military connection indicates the possibil-
ity of a larger proportion of males. The percentages of male par-
ticipants ranged from 32% (Kowall 1996) to 80% (Whittingham
2004). Whittingham 2004, which involved military recruits, had
the youngest population (mean age 18.7 years) and Mason 2011,
the oldest population (mean age 45 years). Notably, Mason 2011,
which had a wider age range of 13 to 82 years, specifically did not
exclude patients with arthritis of the patellofemoral joint. Cases
were described as “acute” in Whittingham 2004. While some par-
ticipants, such as in Mason 2011, were under 18 years of age, we
anticipate these would have been few in number. The duration
of symptoms was at least one month and generally much longer
in the other four trials. The mean duration of symptoms was 2.5
years in Kowall 1996, 71 months in Mason 2011, and 1.8 years
in Tunay 2003. In Clark 2000a, 74% had symptoms for over 12
months. No details of previous treatment, if any, were provided in
these four trials.
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Interventions
Where available, details of the different methods (type and tech-
nique) for taping used in the five trials are presented in the
Characteristics of included studies.
Clark 2000a had four treatment groups, and made two compar-
isons.
Two studies (Clark 2000a;Mason 2011) compared taping with no
taping. All participants in these trials received education or advice.
Four trials (Clark 2000a; Kowall 1996; Tunay 2003;Whittingham
2004) compared taping with exercises versus exercises without
taping. As for the above comparison, all participants in Clark
2000a received education. In Tunay 2003, all participants had ice
applied.Whittingham 2004 had two control groups, one of which
had placebo taping. The intensity and length of treatmentwas very
varied: for example, length of treatment ranged from one week in
Mason 2011 to three months in Clark 2000a.
None of the trials reported on the prescription or use of analgesics.
However, advice on pain controlling drugs was part of the educa-
tion intervention provided in Clark 2000a.
Outcomes
Follow-up assessment was at the end of treatment in all five trials.
Clark 2000a also followed up participants at 12 months.
All five trials recorded participants’ pain levels using the visual
analogue scale/score (VAS). The definitions of pain varied. Clark
2000a combined the results from two pain outcomes (one for
climbing stairs and one for flat walking); Kowall 1996 measured
pain during activities of daily living; Mason 2011 measured pain
scores for four activities, including a self selected activity; Tunay
2003 did not provide details; and Whittingham 2004 reported
average 24 hour pain and pain on stepping down.
Functional Index Questionnaire (FIQ) scores were reported by
Whittingham 2004; Cincinnati knee activity score data were re-
ported by Tunay 2003; WOMAC scores at end of treatment and
12 months by Clark 2000a. Clark 2000a also provided data on
referral post-treatment and further physiotherapy, reported at 12
months.
Excluded studies
The reasons for excluding 36 studies are given in the
Characteristics of excluded studies. Twenty-five studies were ex-
cluded because they only assessed the effect of patellar taping
immediately post-application. Seven trials were excluded because
they did not compare taping with no or placebo taping. The re-
maining four studies were excluded for a variety of other reasons.
Risk of bias in included studies
For more information about the risk of bias assessment, please see
Figure 1 and Figure 2.
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Figure 1. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
The independent administration of pre-numbered sealed en-
velopes meant that Mason 2011 was considered at low risk of
selection bias. There was insufficient information to determine
whether allocation concealment was achieved inClark 2000a. The
other three trials were considered at high risk of selection bias, re-
lating to lack of allocation concealment. This was retrospective in
Kowall 1996, where patients consented after randomisation but
no details were given as to whether any refused consent.
Blinding
A major risk of bias was that no studies were able to blind the
therapists who were giving the treatment. This was a difficult area
to control because by the very nature of the complex interventions
used, it was generally not possible to blind the participants to
treatment.
Three studies (Clark 2000a; Mason 2011; Whittingham 2004)
were considered to have achieved assessor blinding and thus were
at low risk of detection bias.
Incomplete outcome data
Two trials (Clark 2000a; Whittingham 2004) were judged at low
risk of attrition bias. Two trials (Kowall 1996; Mason 2011) were
judged at high risk of bias, in part relating to potential unit of
analyses problems reflecting the inclusion of bilateral cases. Tunay
2003 was judged at unclear risk of attrition bias.
Other potential sources of bias
Assessment of other bias resulted in a judgement of ’unclear risk’ in
three trials (Clark 2000a; Kowall 1996; Tunay 2003) and low risk
in Whittingham 2004. However, we considered Mason 2011 was
at high risk of bias given the lack of information on baseline char-
acteristics and potential imbalance in people with patellofemoral
osteoarthritis.
Effects of interventions
The effects of patellar taping were assessed by the main outcome
measures of pain, functional scores, activity levels and quality of
life. The two comparisons (taping versus no taping, and taping
plus exercise versus exercise and no taping) are presented as two
subgroups. The results for the two control groups ofWhittingham
2004 were combined.
Pain during activities or at rest
Various pain data from four trials are presented in Analysis 1.1 us-
ing a random-effects model given the very significant heterogene-
ity (mean difference (MD) -0.15; 95% confidence interval (CI) -
1.15 to 0.85; heterogeneity: Chi² = 25.78, df = 4 (P < 0.0001); I²
= 84%). The footnotes of Analysis 1.1 give details of the pain as-
sessment and data for each trial. Pooled data from three of the four
trials testing non-acute cases were homogeneous and also showed
no significant effect, either clinical or statistical of taping on pain
(see Analysis 1.2: MD 0.25; 95% CI -0.26 to 0.77). The test for
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subgroup differences showed no difference between the taping on
its own or when used with exercises (Chi² = 1.15, df = 1 (P =
0.28), I² = 13.0%). There were no usable data from Kowall 1996,
which reported that there was no difference in improvement of
patellofemoral pain between the two groups at four weeks. All
participants of the taping group in Whittingham 2004, which re-
cruited people with acute knee pain, had no pain at end of treat-
ment at four weeks. Clark 2000a found no difference between the
two groups at 12 months for either comparison (see Analysis 1.3).
Function and activities of daily living
All participants of the taping group inWhittingham 2004 had no
problems as rated by the functional index questionnaire (FIQ) at
the end of treatment at four weeks. In contrast, the scores of both
control groups indicated some residual problemswith function (see
Analysis 1.4). Tunay 2003 found significantly better Cincinnati
knee activity scores in the taping group at the end of the three
week treatment period (see Analysis 1.5: MD 8.10, 95% CI 2.93
to 13.27). Clark 2000a found no significant differences between
the two groups for either comparison in the WOMAC scores at
the end of the three months treatment (see Analysis 1.6) or 12
months (see Analysis 1.7).
Clark 2000a also found no significant differences between the
two groups for either comparison in post-treatment referrals (see
Analysis 1.8) or further physiotherapy within 12 months (see
Analysis 1.9).
There were insufficient data for any of other prespecified subgroup
or sensitivity analyses.
D I S C U S S I O N
Summary of main results
Five small heterogeneous trials, including around 200 patients
(216 knees) with a diagnosis of patellofemoral pain syndrome,
were included. All compared taping versus control (no or placebo
taping) and all included one or more co-interventions; this was
prescribed exercise in four trials. Pooled visual analogue data from
four trials (161 knees) for various measures of pain at the end of
treatment (this ranged from one week to three months) showed no
significant benefit from taping. Separately, two trials found better
results after taping for functional index questionnaire data and
Cincinnati knee activity scores. Another trial found no significant
benefit for taping in WOMAC scores at the end of treatment or
at 12 months. The same trial also found no benefit from taping
for subsequent referral or physiotherapy.
Overall completeness and applicability of
evidence
The available evidence from trials testing the clinical effects of tap-
ing is little, amounting at maximum to pooled pain data for 161
knees. Even for this ’exploratory’ analysis, the heterogeneous na-
ture of the trial populations, interventions and outcome measures
(both in timing and definition) is considerable.
In terms of the trial populations, there was considerable varia-
tion in the inclusion criteria and definition of patellofemoral pain
syndrome among and often within the studies. The most com-
mon discrepancy was the length of time the patient had their
patellofemoral pain at the time of recruitment. In one study, which
involved army recruits, this was ’acute’ (Whittingham 2004),
whereas a lower limit of one month or more was applied for the
other four studies. This means that it is possible that the patients
were not comparable. Establishing inclusion and exclusion criteria
for trials of patellofemoral pain syndrome will always be hampered
by the lack of a gold standard diagnostic test for the condition. It
remains essentially a diagnosis of exclusion reliant on description
of symptoms and thorough clinical examination to exclude other
causes of pain at the anterior part of the knee which are not di-
rectly related to the patellofemoral joint. Additionally, our focus
was on non-arthritic patellofemoral pain but inclusion of patients
with patellofemoral osteoarthritis was permitted by Mason 2011
and was likely given the older population and the long duration
of symptoms (up to 15 years) in some patients.
The interventions also varied as did the co-interventions (e.g. exer-
cise, education, ice). Some studies described in detail the method
of taping used, including the technique and also the type of tap-
ing (e.g. Mason 2011), whereas others gave no description (e.g.
Tunay 2003). There are anyway insufficient data to assess if there
are differences in effect between a complex taping technique and a
simple one. The frequency and intensity of taping (and co-inter-
ventions) also varied. Mason 2011, which compared taping ver-
sus control for one week only before moving onto a composite
treatment, commented that “the objective improvement over such
a short time period was unexpected”. Whittingham 2004 found
complete recovery from an acute episode after four weeks in the
group given taping, and good improvement too (perhaps reflect-
ing the advice to stop certain activities) in the two control groups.
This reflects also the variation in the trial populations, but also
links with the assessment of outcome, which was mainly at the
end of the treatment programmes. Only Clark 2000a followed up
trial participants subsequently.
One finding of this review was the disappointing lack of standard-
isation of even a simple outcome measure such as the visual ana-
logue score for pain. This highlights an important methodolog-
ical issue for future researchers into patellofemoral pain in gen-
eral and the use of patellar taping in particular. Adopting a valid,
reliable and standardised pain score is the obvious aim, but true
standardisation is hampered by the fact that patients may declare
different pain inducing activities when they use the visual analogue
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score. These activities usually include stair ascent or descent, squat-
ting, kneeling and prolonged sitting. There was no comparability
among the trials in the use of other measures of pain and function,
or the more generic self-reporting scales such as the WOMAC.
Quality of the evidence
As shown in the risk of bias summary (Figure 1), all five trials
were at high of bias in least one domain, which was invariably
performance bias reflecting the lack of blinding in those applying
the taping and, generally, the trial participants. Poorly described
or conducted randomisation, with insufficient attention to ensur-
ing allocation concealment put three trial at high risk of selection
bias. Assessor blinding, which should be possible for at least some
outcomes, was not done in two studies. Unit of analysis problems,
through the inclusion of patients with problems in both knees,
and the incomplete information on loss to follow-up were also
sources of bias. The quality of the evidence was also hampered
by small sample sizes. Overall, the quality of the evidence, using
the GRADE terminology, lies between ’Low quality’ (“Further re-
search is very likely to have an important impact on our confidence
in the estimate of effect and is likely to change the estimate”) and
’Very low quality’ (“We are very uncertain about the estimate”).
Potential biases in the review process
Aside from the changes, which included incorporating updated
methodology described in Differences between protocol and
review, this review was conducted in accordance with our previ-
ously published protocol. We took care to search extensively for
studies which were in abstract form but might have proceeded to
full publication. We also made great efforts (and were generally
successful) to contact authors of studies which were unpublished
or were uncompleted trials to ascertain whether their data could
be included. Several authors confirmed points for clarification and
sent additional data;most of these trials were eventually considered
to be ineligible because they did not answer our research question.
Agreements and disagreements with other
studies or reviews
Another review in this area has looked at the immediate (very short
term effect) of patellar taping (and bracing) on knee pain with and
without knee osteoarthritis (Warden 2008). There were three tri-
als in Warden 2008 that are also included in this Cochrane review
(Clark 2000a; Kowall 1996; Whittingham 2004). The outcome
used for inWarden 2008 was the visual analogue scale/score (VAS)
(mm) for pain, but no comment was made about the variation
in the nominated activity chosen to score the VAS. Warden 2008
compared also the effects of medial directed, lateral directed patel-
lar taping, sham taping and no taping. No analysis was performed
using other measures of function or activity.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Patellar taping is a relatively inexpensive and regularly used treat-
ment intervention for patellofemoral pain syndrome. It is fre-
quently used as part of an exercise and rehabilitation programme
for this condition. However, the currently available evidence from
trials reporting clinically relevant outcomes is low quality and in-
sufficient to draw conclusions on the effects of taping, whether
used on its own or as part of a treatment programme.
Implications for research
Although the exact mechanism of patellar taping for the treatment
of patellofemoral pain syndrome is unclear, it remains an attractive
intervention in terms of application and potential. The low qual-
ity clinical evidence available so far does not endorse patellar tap-
ing, showing minimal evidence of any effect. It is thus timely that
clinicians’ enthusiasm for this intervention should be put to the
test by conducting large, preferablymulti-centre, good quality and
well reported randomised controlled trials that measure clinically
important outcomes and long-term results. Before this, consen-
sus is required on the diagnosis of patellofemoral pain syndrome,
including the avoidance of including patients with osteoarthritis,
the standardisation of outcome measurement and an acceptable
approach for patellar taping. Some promising progress has been
made in this regard in terms of terminology, including shifting
away from labelling this condition as a syndrome (Ghent 2011).
These are likely to enhance the successful initiation and conduct
of such trials and the acceptability and applicability of their find-
ings.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Clark 2000a
Methods Observer blinded, randomised controlled trial.
Participants UK
81 adults (45 male) with over 3 months of anterior knee pain. Mean age: 27.9 years
(range 16 to 40 years). (Recruited from orthopaedic and rheumatology consultants and
from general practitioners.) Duration of symptoms: 3 (< 3 months); 18 (3 to 12 months)
; 60 (> 12 months)
Inclusion criteria: a history of anterior knee pain of more than three months
Exclusion criteria: a history of true locking, patella dislocation, arthritis, any knee ra-
diograph abnormality, ligament laxity (medial and lateral collateral ligament or anterior
draw test), malignancy, infection, or previous knee physiotherapy
Interventions Six treatments over period of 3 months. Length of time of each treatment not stated
1. Patellar taping, exercise & education (n = 20). Tape was applied from the lateral border
of the patella pulling medially and upwards over the medial femoral condyle. Taping in
this way should reduce pain on the squat test and wall/step down test. If this did not
eliminate the pain then the taping was repeated in knee flexion. Type of tape used is not
described.
2. Exercise & education (n = 20).
3. Patellar taping & education (n = 19). Taping as for group 1.
4. Education (n = 22).
Details of co-interventions
Education: leaflet “Knee pain in young adults” and sessions on (a) an explanation of
the nature of anterior knee pain, the anatomy of the patellofemoral joint, and possible
causes of anterior knee pain; (b) footwear and appropriate sporting activities; (c) pain
controlling drugs; (d) stress relaxation techniques, ice and massage; (e) diet and weight
advice; and (f ) prognosis and self help.
Exercise: stretching to the hamstring, iliotibial band, quadriceps and gastrocnemius
muscles. Eccentric, isotonic and isometric strengthening exercises to the lower limb
Outcomes Measured at baseline, 3 months (end of treatment) and 12 months (via postal question-
naire)
Pain: two VAS: one for climbing stairs and one for flat walking. Total VAS score = 200
mm (adjusted to 10 cm for presentation in the review)
Western Ontario and McMaster University Osteoarthritis Index (WOMAC) scores
Hospital Anxiety and Depression (HAD) scores
Quadriceps strength (Nm)
Patient satisfaction
Discharge/referral post treatment, and further physiotherapy (self-report)
Notes Diary sheet given to help compliance.
Risk of bias
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Clark 2000a (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The patients were then randomly allo-
cated by the physiotherapist to one of four
groups using an individualised computer
generated randomisation programme.”
Allocation concealment (selection bias) Unclear risk Use of “individualised computer generated
randomisation programme”, but insuffi-
cient description of method to ensure allo-
cation concealment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants: not done.
Therapists: not stated and unlikely due to
nature of the treatments
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “A blinded independent observer under-
took the assessment on the sixth visit.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk “10 patients withdrew from the study and
these were included on an intention to treat
basis.” Participant flow provided
Other bias Unclear risk Baseline characteristics of the four groups
were comparable.
“All four groups received the same advice.
” but lack of information on duration of
treatment sessions
Diary sheets given to help compliance in
exercise groups.
Kowall 1996
Methods Randomised study
Participants USA
25 participants (8 male), 10 of whom had bilateral complaints (35 knees). Mean age 29
years (range 14 to 40 years). Duration of symptoms: 2.5 years (range 1 month to 15
years)
Inclusion criteria: unilateral or bilateral patellofemoral pain for more than 1 month,
patient age between 14 and 40 years, ability to complete a 4-week formal physical therapy
programme, and ability to comply with a 4-week home exercise programme.
Exclusion criteria: history or clinical evidence of patellofemoral dislocation, synovial
plicae, or meniscal or ligamentous injury. History of prior knee trauma or knee surgery
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Kowall 1996 (Continued)
Interventions Treatment: twice weekly for 4 weeks
1. Physical therapy and home exercise programme + patellar taping (n = 12 patients)
. Taping technique described as the ’McConnell technique’. Type of tape used is not
described
2. Physical therapy and home exercise group without patellar taping (n = 13 patients)
Details of co-interventions
Exercise: extensive stretching andquadricepsmuscle-strengtheningprogram.Quadriceps
muscle strengthening involved progressive isometric, isotonic, and isokinetic exercises.
Each group was instructed in a standard home exercise programme
Outcomes Measured at baseline and after 4 weeks of treatment
Pain during activities of daily living (VAS: 10 cm)
Isokinetic quadriceps strength (Nm)
EMG (electromyograph) activity of the quadriceps (vastusmedialis / vastus lateralis ratio)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients meeting the eligibility requirements were randomised
... Randomization was accomplished with a prerandomization
technique in which patients were assigned to a treatment group
before consenting to the assigned treatment.” No details of
method of sequence generation
Allocation concealment (selection bias) High risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants: not described.
Therapists: not possible due to the nature of the interventions
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
High risk Intention-to-treat not stated. Dropouts not mentioned. Possible
unit of analysis problems resulting from inclusion of bilateral
cases
Other bias Unclear risk No data to judge baseline comparability of groups; but “The sex
and age of the patients anddurationof symptomswere essentially
the same for Groups I and II.”
Similar care programmes likely.
Home exercise compliance monitored with EMG, and Bio-
Prompt computer whilst doing exercises
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Mason 2011
Methods Double blind, randomised controlled study.
Participants Australia
30 knees belonging to an unknown number of participants with patellofemoral pain.
Overall there were 41 participants (15 males, mean age 45 years, range 13 to 82 years)
, 19 of whom had bilateral complaints (60 knees) recruited into the trial (see Notes).
Duration of symptoms: mean 71 months
Inclusion criteria: at least 1 month of retro or peripatellar pain, aggravated by 2 or more
of the following - squatting, kneeling, ascending or descending stairs, running
Exclusion criteria: patellar tendinitis, Osgood-Schlatter disease, hip joint osteoarthritis,
meniscal symptoms, surgery, rheumatoid arthritis, synovitis, back pain, tibiofemoral
osteoarthritis
Note: Participants with patellofemoral osteoarthritis were not excluded
Interventions One week of treatment.
1. Infrapatellar taping (n = 15 knees). Taping technique involved application of one layer
of 50 mm hypoallergenic non rigid underwrap (Therfix, Physiomedic), three layers of
38 mm rigid zinc oxide (PhysioMed, Ausmedic). Tape applied with posterior, superior
pressure under the patella
2. No treatment control (n = 15 knees).
Details of co-interventions
Education: all trial participants received an overview of knee anatomy and function, and
advice on avoiding painful activities
In the second week, all participants received a composite intervention of patellar taping,
and quadriceps strengthening and stretching exercises
Outcomes Measured at baseline and at weeks 1( post ’singular’ intervention) and 2 week (post
’combined’ interventions (taping, quadriceps strengthening and stretching)). Only week
1 data considered in review
VAS pain scores for 4 activities: ascent of 7 stairs without support; descent of 7 stairs
without support; 18 cm step down leading with non-injured leg; and a self selected
activity
Quadriceps strength isokinetic peak torque at 60º/sec
Quadriceps tightness (length), prone lying heel to buttock distance with tape measure
Pain free eccentric knee angle control test.
Notes Data from the two other groups of this trial are not included in this review. One excluded
group (15 knees) was given quadriceps strengthening with end range open chain knee
extension; and the other group (15 knees) was given quadriceps stretching to rectus
femoris in position individualised to each patient
Random group allocation was performed and allocation concealment maintained by an
independent person overseeing a sealed envelope method
Patients completed a daily exercise compliance diary.
Risk of bias
Bias Authors’ judgement Support for judgement
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Mason 2011 (Continued)
Random sequence generation (selection
bias)
Low risk Participants were “randomly allocated to
one of four groups according to a selected,
sealed and pre-numbered envelope”. (De-
tails of sequence generation were, however,
missing.)
Allocation concealment (selection bias) Low risk “sealed and pre-numbered envelope”. Not
described in text but clarified as being con-
ducted by an independent person by the
lead author through personal communica-
tion (see Notes above)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants: not possible due to the nature
of the interventions.
Therapists: the treating therapist was not
blinded to the treatment grouping of the
subjects
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Strategies to maintain assessor blinding de-
scribed as: “All subjects were asked to wear
long pants for the end of the first week as-
sessment so that the assessing physiother-
apist remained blinded towards the single
modality treatment during that week.”
Incomplete outcome data (attrition bias)
All outcomes
High risk No report of intention-to-treat analysis.No
mention of drop outs. Possible unit of anal-
ysis problems resulting from inclusion of
bilateral cases
Other bias High risk Mixture of
osteoarthritis patellofemoral pain patients
with non-osteoarthritis patellofemoral pain
patients. Numbers with each pathology not
described. No data describing comparabil-
ity of groups at entry
No information on comparability of other
care but likely.
“Each subject completed a weekly exer-
cise diary indicating the number of sessions
completed each day.”
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Tunay 2003
Methods Randomised study
Participants Turkey
40 participants with unilateral patellofemoral pain syndrome (no information on gender
but likely to be mainly males given possible military connection). Mean age: 30.3 years.
Duration of symptoms: mean 1.8 years (range 1 month to 5 years)
Inclusion criteria: unilateral patellofemoral pain syndrome not less than 1 month
Exclusion criteria: history or clinical findings of patellar dislocation, meniscal or liga-
mentous injury, synovial plicae, knee surgery and trauma
Interventions Treatment for 3 weeks (15 sessions in total)
1. Patellar taping, ice and home exercises (n = 20)
2. Ice and home exercises (n = 20)
Details of co-interventions
Exercise: not described.
Ice: not described.
Outcomes Measured at baseline and after 3 weeks of treatment
Pain intensity (VAS: 10 cm)
Cincinnati Knee Activity Rating Scale
Congruence angle, sulcus angle and patellar tilt angle from magnetic resonance imaging
(MRI)
The ’Q’ angle
Hamstring and iliotibial band flexibility
Thigh circumference measurement
Leg-length discrepancy
Notes Data from the two other groups of this trial are not included in this review. One of these
groups (20 participants) was given ice, electrical nerve stimulation, medial patellar glide
and exercise by a physiotherapist; and the other group (20 participants) was given ice,
electrical nerve stimulation, patellar taping and exercise by a physiotherapist
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “A prospective randomized studywas designed ...” “The patients
were divided into 4 groups matched for age and gender ....”. No
details of how randomised
Allocation concealment (selection bias) High risk Not described, but use of “matching” is of concern.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants: not described.
Therapists: not possible due to the nature of the interventions
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Evaluations were described as being “done by an orthopaedic
surgeon”. No other details
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Tunay 2003 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Intention-to-treat not mentioned. Unclear if there are drop outs
Other bias Unclear risk Comparable baseline characteristics.
Lack of information to judge performance bias from differences
in other care
No compliance monitoring
Whittingham 2004
Methods Randomised controlled trial
Participants UK (military)
30 (male = 24) army recruits with a diagnosis of acute patellofemoral pain syndrome
referred for physiotherapy by the Unit Medical Officer. Mean age 18.7 years. Duration
of symptoms: acute
Inclusion criteria: recruits with two from the following - pain on ascending and/or
descending stairs, squatting, sitting for extended periods of time, or associated with an
increase in physical activity. Aged 17 to 25 years, and able to give informed consent
Exclusion criteria: history of subluxation or dislocation of the patella, anterior or poste-
rior cruciate ligament insufficiency, previous knee surgery or meniscal damage, or any
other underlying musculoskeletal problems that would have prevented the subject from
performing the exercises
Interventions Treatment for 4 weeks; daily sessions (no home exercises)
1. Patella taping and a standardised exercise programme (n= 10). Active taping technique:
underwrap and one corrective strip of tape. Correction of patellar malalignments of tilt,
rotation or glide as identified by the treating physiotherapist
2. Placebo taping and the same exercise programme (n = 10). Placebo taping: underwrap
and one strip of tape with no correction of patellar position
3. Same exercise programme alone (n = 10)
Type of adhesive tape not described.
Details of co-interventions
Exercise: non-weight-bearing isometric, inner-range isotonic and straight leg raise quadri-
ceps exercises. A variety of weight-bearing exercises (e.g. squats). Stretches for the quadri-
ceps, hamstrings, gastrocnemius, and iliotibial band. No home exercise programme
Outcomes Measured at baseline and at weeks 1, 2, 3 and 4 during treatment
VAS pain scores (10 cm): average over last 24 hours; during stepping down activity with
tape and without tape applied
Functional index questionnaire
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Whittingham 2004 (Continued)
Random sequence generation (selection
bias)
Low risk “A block randomisation process was used, where subjects
randomly chose 1 of 3 labelled envelopes to determine
their group allocation. The next subject chose 1 of the
remaining 2 envelopes and the third person was then
assigned to the remaining group before the process was
repeated. This ensured that there were even numbers of
subjects in each group.”
Allocation concealment (selection bias) High risk As described above. The allocation was not concealed for
every third patient
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants: not possible due to the nature of the inter-
ventions
Therapists: the treating therapist, “who was aware of
group allocation, applied adhesive tape to the affected
knee of subjects in the taping group and placebo taping
group”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The assessor, who was blinded to group allocation, took
all outcome measures
Incomplete outcome data (attrition bias)
All outcomes
Low risk “All subjects remained in the group to which they were
originally assigned.”
Other bias Low risk Baseline characteristics comparable in the three groups.
“All subjects were placed on restricted duties (similar for
all individuals) throughout the treatment period.” Every
participant attended daily at the same time for 4 weeks
duration of the study (study was in a military setting)
No home exercise programme prescribed and exercise
compliance not needed
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abd Elhafz Yehia 2011 This study was excluded because it compared open versus closed kinetic exercises; both groups received
taping
Aminaka 2008 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Aminaka 2010 Published abstract with immediate pre and post taping effect
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(Continued)
Arcand 1998 Abstract with immediate pre and post taping effect.
Aytar 2011 The trial assessed patients within 45 minutes of application of the tape and not as part of a treatment
programme
Bockrath 1993 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Cerny 1995a The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Christou 2004 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Collins 2008 This was a single blinded randomised clinical trial primarily assessing foot orthotics. There was a group
that had taping, but also had multimodal physiotherapy including stretching, exercise, education and
biofeedback. Therefore it was difficult to guarantee that taping alone would cause the beneficial effect found
in the study
Conway 1992 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Cowan 2002b The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Crome 1984 Abstract. The trial assessed the effect of taping on pain immediately post application and not as part of a
treatment programme
Crossley 2002 This trial compared physical therapy,which included patellar taping, versus placebo therapy,which included
placebo taping. It is excluded because it would be impossible to attribute the results to patellar taping alone
Derasari 2010 The trial assessed the effect of taping on kinematically assessed patellar position immediately post application
and not as part of a treatment programme
Eburne 1996 Group 1 received no tape and Group 2 received tape. However, the two groups received different exercise
regimens. So this study was excluded as the two programmes were substantially different to be certain that
the differences were solely due to the allocation of tape
Ernst 1999 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Gerrard 1989 The study was an uncontrolled, non-randomised trial of taping as part of an exercise programme
Gilleard 1998 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
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(Continued)
Handfield 2000 The trial assessed the effect of taping on pain immediately and 24 hours post application and not as part of
a treatment programme
Harrison 1999 This study was excluded because Group 2 received education and a strength and stretching programme but
Group 3 received not only taping additionally, but also biofeedback. Therefore it cannot be guaranteed that
taping was the sole different intervention between the groups
Herrington 2001 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Jancaitis 2007 Abstract. Two days of taping versus sham taping. Personal communication with author revealed that data
were not available for fuller analysis
Kaya 2010 Although this has a three month patellar taping programme, all patellofemoral pain syndrome patients
received taping.This is a within-group trial using the healthy knee for comparison and with a healthy control
group
Keet 2007 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Lan 2010 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Loudon 2004 Although this was an eight week exercise programme, it was excluded because all groups including the
control group received patellar taping
Mostamand 2010 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Nafstad 1996 This study was excluded because it compared exercise plus tape versus exercise plus elastic patellar brace
Ng 2002 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Powers 1997a The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Salsich 2002 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Selfe 2010a Abstract reporting immediate pre and post taping effect only
Somes 1997 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Werner 1993 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
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(Continued)
Wijnen 1996 This was excluded for two reasons. Firstly, it compared patellar taping with an elasticated knee bandage
so there was no ’no-taping’ group. Secondly it was not possible to ascertain if the exercise programmes for
both groups were comparable as there were no details for the programme given to the ’Couman group’
Wilson 2003 The trial assessed the effect of taping on pain immediately post application and not as part of a treatment
programme
Characteristics of studies awaiting assessment [ordered by study ID]
Miller 2010
Methods Randomised controlled trial
Participants Females with unilateral or bilateral patellofemoral pain syndrome. History of patellofemoral pain over a period of six
weeks; “top scores from patellar orientation tests”
Interventions 8 week treatment period
1. Taping plus exercise
2. Exercise only
Outcomes Measured at weeks 1, 4 and 8 weeks
Pain, functional activity.
Notes Abstract only. Thirty volunteers but probably fewer after tests; also a third group (no treatment control) is not eligible
for this review. The numbers randomised into the three groups are not reported
26Patellar taping for patellofemoral pain syndrome in adults (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Patellar taping versus no or placebo taping
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain: VAS (0: no pain to 10:
worst pain) at end of treatment
4 161 Mean Difference (IV, Random, 95% CI) -0.15 [-1.15, 0.85]
1.1 No exercise
co-intervention
2 62 Mean Difference (IV, Random, 95% CI) -0.10 [-0.91, 0.72]
1.2 Same exercises given to all
participants
3 99 Mean Difference (IV, Random, 95% CI) -0.16 [-1.67, 1.34]
2 Pain: VAS (0: no pain to 10:
worst pain) at end of treatment
(no ’acute’ cases)
3 141 Mean Difference (IV, Fixed, 95% CI) 0.25 [-0.26, 0.77]
2.1 No exercise
co-intervention
2 62 Mean Difference (IV, Fixed, 95% CI) -0.10 [-0.91, 0.72]
2.2 Same exercises given to all
participants
2 79 Mean Difference (IV, Fixed, 95% CI) 0.48 [-0.18, 1.14]
3 Pain: VAS (0: no pain to 10:
worst pain) at 12 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 No exercise
co-intervention
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Same exercises given to all
participants
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Functional index questionnaire
(FIQ) score (16 = no problems)
at end of treatment
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 No exercise co-
intervention
0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Same exercises given to all
participants
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Cincinnati knee activity score
(100 = full activity) at end of
treatment
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 No exercise co-
intervention
0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 Same exercises given to all
participants
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 WOMAC score (0: no problems
to 96: extreme problems) at
end of treatment
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 No exercise
co-intervention
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Same exercises given to all
participants
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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7 WOMAC score (0: no problems
to 96: extreme problems) at 12
months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 No exercise
co-intervention
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Same exercises given to all
participants
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Referred for further treatment
(after 3 months)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 No exercise
co-intervention
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 Same exercises given to all
participants
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Further course of physiotherapy
(after 3 months)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
9.1 No exercise
co-intervention
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 Same exercises given to all
participants
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Analysis 1.1. Comparison 1 Patellar taping versus no or placebo taping, Outcome 1 Pain: VAS (0: no pain to
10: worst pain) at end of treatment.
Review: Patellar taping for patellofemoral pain syndrome in adults
Comparison: 1 Patellar taping versus no or placebo taping
Outcome: 1 Pain: VAS (0: no pain to 10: worst pain) at end of treatment
Study or subgroup Tape No or placebo tape
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 No exercise co-intervention
Clark 2000a (1) 16 1.8 (1.44) 16 1.5 (2) 18.2 % 0.30 [ -0.91, 1.51 ]
Mason 2011 (2) 15 1.83 (1.6) 15 2.26 (1.5) 19.0 % -0.43 [ -1.54, 0.68 ]
Subtotal (95% CI) 31 31 37.1 % -0.10 [ -0.91, 0.72 ]
Heterogeneity: Tau?? = 0.0; Chi?? = 0.76, df = 1 (P = 0.38); I?? =0.0%
Test for overall effect: Z = 0.23 (P = 0.82)
2 Same exercises given to all participants
Clark 2000a (3) 18 2.89 (1.94) 21 2.08 (2.03) 17.9 % 0.81 [ -0.44, 2.06 ]
Tunay 2003 (4) 20 2.7 (1.38) 20 2.35 (1.13) 21.5 % 0.35 [ -0.43, 1.13 ]
Whittingham 2004 (5) 10 0 (0.1) 10 1.45 (0.73) 23.5 % -1.45 [ -1.91, -0.99 ]
Subtotal (95% CI) 48 51 62.9 % -0.16 [ -1.67, 1.34 ]
Heterogeneity: Tau?? = 1.57; Chi?? = 22.47, df = 2 (P = 0.00001); I?? =91%
(5) Pain on step down. 0.1 added in as SD for Tape group to show data. At 4 weeks.
(Continued . . . )
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(. . . Continued)
Study or subgroup Tape No or placebo tape
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 0.21 (P = 0.83)
Total (95% CI) 79 82 100.0 % -0.15 [ -1.15, 0.85 ]
Heterogeneity: Tau?? = 1.05; Chi?? = 25.78, df = 4 (P = 0.00004); I?? =84%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Chi?? = 0.01, df = 1 (P = 0.94), I?? =0.0%
-4 -2 0 2 4
Favours tape Favours no tape
(1) Combined VAS (pain on climbing stairs and flat walking) / 20. At 3 months.
(2) Pain for self-reported activity. At 1 week. Note this is for knees not patients.
(3) Combined VAS (pain on climbing stairs and flat walking) / 20. At 3 months.
(4) Pain (not described). At 3 weeks.
(5) Pain on step down. 0.1 added in as SD for Tape group to show data. At 4 weeks.
Analysis 1.2. Comparison 1 Patellar taping versus no or placebo taping, Outcome 2 Pain: VAS (0: no pain to
10: worst pain) at end of treatment (no ’acute’ cases).
Review: Patellar taping for patellofemoral pain syndrome in adults
Comparison: 1 Patellar taping versus no or placebo taping
Outcome: 2 Pain: VAS (0: no pain to 10: worst pain) at end of treatment (no ’acute’ cases)
Study or subgroup Tape No or placebo tape
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 No exercise co-intervention
Clark 2000a 16 1.8 (1.44) 16 1.5 (2) 18.2 % 0.30 [ -0.91, 1.51 ]
Mason 2011 15 1.83 (1.6) 15 2.26 (1.5) 21.5 % -0.43 [ -1.54, 0.68 ]
Subtotal (95% CI) 31 31 39.7 % -0.10 [ -0.91, 0.72 ]
Heterogeneity: Chi?? = 0.76, df = 1 (P = 0.38); I?? =0.0%
Test for overall effect: Z = 0.23 (P = 0.82)
2 Same exercises given to all participants
Clark 2000a 18 2.89 (1.94) 21 2.08 (2.03) 17.0 % 0.81 [ -0.44, 2.06 ]
Tunay 2003 20 2.7 (1.38) 20 2.35 (1.13) 43.3 % 0.35 [ -0.43, 1.13 ]
Subtotal (95% CI) 38 41 60.3 % 0.48 [ -0.18, 1.14 ]
-4 -2 0 2 4
Favours tape Favours no tape
(Continued . . . )
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(. . . Continued)
Study or subgroup Tape No or placebo tape
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Heterogeneity: Chi?? = 0.37, df = 1 (P = 0.54); I?? =0.0%
Test for overall effect: Z = 1.42 (P = 0.16)
Total (95% CI) 69 72 100.0 % 0.25 [ -0.26, 0.77 ]
Heterogeneity: Chi?? = 2.29, df = 3 (P = 0.52); I?? =0.0%
Test for overall effect: Z = 0.96 (P = 0.34)
Test for subgroup differences: Chi?? = 1.15, df = 1 (P = 0.28), I?? =13%
-4 -2 0 2 4
Favours tape Favours no tape
Analysis 1.3. Comparison 1 Patellar taping versus no or placebo taping, Outcome 3 Pain: VAS (0: no pain to
10: worst pain) at 12 months.
Review: Patellar taping for patellofemoral pain syndrome in adults
Comparison: 1 Patellar taping versus no or placebo taping
Outcome: 3 Pain: VAS (0: no pain to 10: worst pain) at 12 months
Study or subgroup Tape No or placebo tape
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 No exercise co-intervention
Clark 2000a 12 3.87 (3.14) 15 2.59 (2.69) 1.28 [ -0.96, 3.52 ]
2 Same exercises given to all participants
Clark 2000a 10 1.76 (2.26) 12 1.89 (2.17) -0.13 [ -1.99, 1.73 ]
-4 -2 0 2 4
Favours tape Favours no tape
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Analysis 1.4. Comparison 1 Patellar taping versus no or placebo taping, Outcome 4 Functional index
questionnaire (FIQ) score (16 = no problems) at end of treatment.
Review: Patellar taping for patellofemoral pain syndrome in adults
Comparison: 1 Patellar taping versus no or placebo taping
Outcome: 4 Functional index questionnaire (FIQ) score (16 = no problems) at end of treatment
Study or subgroup Tape No or placebo tape
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 No exercise co-intervention
2 Same exercises given to all participants
Whittingham 2004 10 16 (0.1) 10 13.5 (1.1) 2.50 [ 1.82, 3.18 ]
-4 -2 0 2 4
Favours no tape Favours tape
Analysis 1.5. Comparison 1 Patellar taping versus no or placebo taping, Outcome 5 Cincinnati knee activity
score (100 = full activity) at end of treatment.
Review: Patellar taping for patellofemoral pain syndrome in adults
Comparison: 1 Patellar taping versus no or placebo taping
Outcome: 5 Cincinnati knee activity score (100 = full activity) at end of treatment
Study or subgroup Tape No or placebo tape
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 No exercise co-intervention
2 Same exercises given to all participants
Tunay 2003 20 83 (8.3) 20 74.9 (8.39) 8.10 [ 2.93, 13.27 ]
-10 -5 0 5 10
Favours no tape Favours tape
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Analysis 1.6. Comparison 1 Patellar taping versus no or placebo taping, Outcome 6 WOMAC score (0: no
problems to 96: extreme problems) at end of treatment.
Review: Patellar taping for patellofemoral pain syndrome in adults
Comparison: 1 Patellar taping versus no or placebo taping
Outcome: 6 WOMAC score (0: no problems to 96: extreme problems) at end of treatment
Study or subgroup Tape No or placebo tape
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 No exercise co-intervention
Clark 2000a 18 20.9 (15.5) 21 13.8 (15.8) 7.10 [ -2.75, 16.95 ]
2 Same exercises given to all participants
Clark 2000a 16 11.5 (10.5) 16 10 (11.8) 1.50 [ -6.24, 9.24 ]
-10 -5 0 5 10
Favours tape Favours no tape
Analysis 1.7. Comparison 1 Patellar taping versus no or placebo taping, Outcome 7 WOMAC score (0: no
problems to 96: extreme problems) at 12 months.
Review: Patellar taping for patellofemoral pain syndrome in adults
Comparison: 1 Patellar taping versus no or placebo taping
Outcome: 7 WOMAC score (0: no problems to 96: extreme problems) at 12 months
Study or subgroup Tape No or placebo tape
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 No exercise co-intervention
Clark 2000a 12 27.6 (22.7) 15 22 (21.3) 5.60 [ -11.17, 22.37 ]
2 Same exercises given to all participants
Clark 2000a 10 14.8 (18) 12 15.6 (16.2) -0.80 [ -15.24, 13.64 ]
-20 -10 0 10 20
Favours tape Favours no tape
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Analysis 1.8. Comparison 1 Patellar taping versus no or placebo taping, Outcome 8 Referred for further
treatment (after 3 months).
Review: Patellar taping for patellofemoral pain syndrome in adults
Comparison: 1 Patellar taping versus no or placebo taping
Outcome: 8 Referred for further treatment (after 3 months)
Study or subgroup Tape No or placebo tape Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 No exercise co-intervention
Clark 2000a 11/19 9/22 1.42 [ 0.75, 2.66 ]
2 Same exercises given to all participants
Clark 2000a 1/20 0/20 3.00 [ 0.13, 69.52 ]
0.01 0.1 1 10 100
Favours tape Favours no tape
Analysis 1.9. Comparison 1 Patellar taping versus no or placebo taping, Outcome 9 Further course of
physiotherapy (after 3 months).
Review: Patellar taping for patellofemoral pain syndrome in adults
Comparison: 1 Patellar taping versus no or placebo taping
Outcome: 9 Further course of physiotherapy (after 3 months)
Study or subgroup Tape No or placebo tape Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 No exercise co-intervention
Clark 2000a 3/19 5/22 0.69 [ 0.19, 2.53 ]
2 Same exercises given to all participants
Clark 2000a 2/20 2/20 1.00 [ 0.16, 6.42 ]
0.01 0.1 1 10 100
Favours tape Favours no tape
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A P P E N D I C E S
Appendix 1. Search strategies
The Cochrane Library (Wiley InterScience)
#1 MeSH descriptor Arthralgia, this term only
#2 MeSH descriptor Patella, this term only
#3 (patellofemoral or patello-femoral) NEAR/3 (joint*):ti,ab,kw
#4 (#2 OR #3)
#5 (#1 AND #4)
#6 (anterior knee pain):ti,ab,kw
#7 MeSH descriptor Patellofemoral Pain Syndrome, this term only
#8 (patellofemoral or patello-femoral) ADJ (pain or syndrome or dysfunction):ti,ab,kw
#9 (lateral compression or lateral facet or lateral pressure or odd facet) ADJ (syndrome):ti,ab,kw
#10 MeSH descriptor Chondromalacia Patellae, this term only
#11 (chrondromal* or chondropath*) ADJ (knee or patell* or femoropatell* or femoro-patell* or regropatell* or retro-patell*):ti,ab,kw
#12 (#6 OR #7 OR #8 OR #9 OR #10 OR #11)
#13 (taping or tape*):ti,ab,kw
#14 strap*:ti,ab,kw
#15 McConnell AND (knee* or patell*):ti,ab,kw
#16 (#13 OR #14 OR #15)
#17 (#5 OR #12)
#18 (#16 AND #17)
MEDLINE (OVID ONLINE)
1. Arthralgia/
2. Patella/
3. ((patellofemoral or patello-femoral) adj (joint)).tw
4. 1 and (or/2-3)
5. anterior knee pain.tw
6. Patellofemoral pain syndrome/
7. ((Patello-femoral or patellofemoral) adj (pain or syndrome or dysfunction)).tw
8. ((lateral compression or lateral facet or lateral pressure or odd facet) adj (syndrome)).tw
9. Chondromalacia patellae/
10. ((chondromal$ or chondropath$) adj (knee or patell$ or femoropatell$ or femoro-patell$ or retropatell$ or retro-patell$)).tw
11. or/5-10
12. (taping or tape$).tw
13. strap$.tw
14. (McConnell and (knee$ or patell$)).tw
15. or/12-14
16. (or/4,11) and 15
17. randomized controlled trial.pt
18. controlled clinical trial.pt
19. Randomized Controlled Trials/
20. Random Allocation/
21. Double Blind Method/
22. Single Blind Method/
23. or/17-22
24. Animals/ not Humans/
25. 23 not 24
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26. clinical trial.pt
27. exp Clinical Trials as topic/
28. (clinic$ adj25 trial$).tw
29. ((singl$ or doubl$ or trebl$ or tripl$) adj (mask$ or blind$)).tw
30. Placebos/
31. placebo$.tw
32. random$.tw
33. Research Design/
34. or/26-33
35. 34 not 24
36. 35 not 25
37. or/25,36
38. and/16,37
EMBASE (OVID ONLINE)
1. Arthralgia/
2. Patella/
3. Patellofemoral joint/
4. 1 and (or/2,3)
5. anterior knee pain.tw
6. Patellofemoral pain syndrome/
7. ((patello-femoral or patellofemoral) adj (pain or syndrome or dysfunction)).tw
8. ((lateral compression or lateral facet or lateral pressure or odd facet) adj (syndrome)).tw
9. Patella chondromalacia/
10. ((chondromal$ or chondropath$) adj (knee or patell$ or femoropatell$ or femoro-patell$ or retropatell$ or retro-patell$)).tw
11. or/5-10
12. (taping$ or tape$).tw
13. strap$.tw
14. (McConnell and (knee or patell$)).tw
15. or/12-14
16. (or/4,11) and 15
17. Clinical trial/
18. Randomized Controlled trial/
19. Randomisation/
20. Double Blind Procedure/
21. Single Blind Procedure/
22. Crossover Procedure/
23. Placebo/
24. randomi?ed controlled trial$.tw
25. RCT.tw
26. random allocation.tw
27. randomly allocated.tw
28. allocated randomly.tw
29. (allocated adj2 random).tw
30. single blind$.tw
31. double blind$.tw
32. ((triple or treble) adj (blind$)).tw
33. placebo$.tw
34. Prospective study/
35. or/17-34
36. Case study/
37. case report.tw
35Patellar taping for patellofemoral pain syndrome in adults (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
38. Abstract report/ or Letter/
39. or/36-38
40. 35 not 39
41. limit 40 to human
42. and/16,41
CINAHL (EBSCO)
1. Arthralgia/
2. Patella/
3. ((patellofemoral or patello-femoral) adj (joint)).tw
4. 1 and (or/2,3)
5. anterior knee pain.tw
6. Patellofemoral pain syndrome/
7. ((patello-femoral or patellofemoral) adj (pain or syndrome or dysfunction)).tw
8. ((lateral compression or lateral facet or lateral pressure or odd facet) adj (syndrome)).tw
9. Chondromalacia patella/
10. ((chondromal$ or chondropath$) adj (knee or patell$ or femoro$ or femoro-patell$ or retropatell$ or retro-patell$)).tw
11. or/5-10
12. “Taping and strapping”/
13. (taping or tape$).tw
14. strap$.tw
15. (McConnell and (knee$ or patell$)).tw
16. or/12-15
17. (or/4,11) and 16
18. exp Clinical Trials/
19. exp Evaluation Research/
20. exp Comparative Studies/
21. exp Crossover Design/
22. clinical trial.pt
23. or/18-22
24. ((clinical or controlled or comparative or placebo or prospective or randomi#ed) adj3 (trial or study)).tw
25. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).tw
26. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).tw
27. (cross?over$ or (cross adj1 over$)).tw
28. ((allocat$ or allot$ or assign$ or divid$) adj3 (condition$ or experiment$ or intervention$ or treatment$ or therap$ or control$ or
group$)).tw
29. or/24-28
30. or/23,29
31. and/17,30
PEDro
Abstract & Title: (tape* or taping)
Therapy: no selection
Problem: no selection
Body part: lower leg or knee
Subdiscipline: no selection
Method: clinical trial
Match all search terms (AND)
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SPORTDiscus (EBSCO)
1. Knee/
2. Knee joint/
3. Patella/
4. Patellofemoral joint/
5. or/1-4
6. anterior knee pain.tw
7. Patellofemoral pain syndrome/
8. ((patello-femoral or patellofemoral) adj (pain or syndrome or dysfunction)).tw
9. ((lateral compression or lateral facet or lateral pressure or odd facet) adj (syndrome)).tw
10. Chondromalacia/
11. (chondromal$ or chondropath$) adj (knee or patell$ or femoropatell$ or femoro-patell$ or retropatell$ or retro-patell$).tw
12. or/ 6-11
13. (tape$ or taping).tw
14. strap$.tw
15. (McConnell and (knee$ or patell$)).tw
16. or/13-15
17. (or/ 5,12) and 16
18. ((clinic$ or controlled or comparative or placebo or prospective or randomi#ed) adj3 (trial or study)).tw
19. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).tw
20. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).tw
21. (cross?over$ or (cross adj1 over$)).tw
22. randomi?ed control$ trial$.tw
23. ((allocat$ or allot$ or assign$ or divid$) adj3 (condition$ or experiment$ or intervention$ or treatment$ or therap$ or control$ or
group$)).tw
24. placebo$.tw
25. or/18-24
30. and/17,25
AMED (OVID ONLINE)
1. Arthralgia/
2. Patella/
3. ((patellofemoral or patello-femoral) adj (joint)).tw
4. 1 and (or/2,3)
5. anterior knee pain.tw
6. Patellofemoral pain/
7. ((patello-femoral or patellofemoral) adj (pain or syndrome or dysfunction)).tw
8. ((lateral compression or lateral facet or lateral pressure or odd facet) adj (syndrome)).tw
9. ((chondromal$ or chondropath$) adj (knee or patell$ or femoro$ or femoro-patell$ or retropatell$ or retro-patell$)).tw
10. or/ 5-9
11. (taping or tape$).tw
12. strap$.tw
13. ((McConnell) and (knee$ or patell$)).tw
14. or/11-13
15. (or/4,10) and 14
16. randomized controlled trial.pt
17. controlled clinical trial.pt
18. Randomized Controlled Trials/
19. Random Allocation/
20. Double-Blind Method/
21. or/16-20
22. Animals/ not Humans/
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23. 21 not 22
24. clinical trial.pt
25. exp Clinical Trials/
26. (clinic$ adj25 trial$).tw
27. ((singl$ or doubl$ or trebl$ or tripl$) adj (mask$ or blind$)).tw
28. Placebos/
29. placebo$.tw
30. random$.tw
31. Research Design/
32. (latin adj square).tw
33. or/24-32
34. 33 not 22
35. 34 not 23
36. and/15,23
37. and/15,35
38. or/ 36,37
H I S T O R Y
Protocol first published: Issue 3, 2007
Review first published: Issue 4, 2012
Date Event Description
11 September 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
Michael Callaghan and James Selfe conceived the idea and wrote the protocol. They performed the search, performed study selection,
reviewed the included studies and drafted the review. Michael Callaghan is the guarantor of the review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
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Internal sources
• University of Manchester, UK.
• University of Central Lancashire, UK.
External sources
• Department of Health Post Doctoral Award, UK.
• Arthritis Research, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We clarified that our intention was to compare tape versus no or placebo tape and thus we excluded studies that compared patellar
taping with another intervention (such as exercises) or that compared composite interventions, that included patellar taping, with no
intervention or different interventions.
In the protocol under the title ’Timepoints considered’, we stated that we would consider studies that analysed the effect of patellar
taping immediately post application. We have removed this and have only considered patellar taping when it was used as part of a
treatment programme for a sustained period. We have also removed ’change of range of motion’ as one of the ’Types of outcome
measures’.
In accordance with the latest Cochrane recommendations, we have completely replaced the quality assessment tool with the ’Risk of
bias’ tool.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Bandages; ∗Surgical Tape; Pain Measurement [methods]; Patellofemoral Pain Syndrome [∗therapy]; Randomized Controlled Trials as
Topic; Treatment Outcome
MeSH check words
Adult; Humans
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